These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 33704068)

  • 1. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
    Gisby J; Clarke CL; Medjeral-Thomas N; Malik TH; Papadaki A; Mortimer PM; Buang NB; Lewis S; Pereira M; Toulza F; Fagnano E; Mawhin MA; Dutton EE; Tapeng L; Richard AC; Kirk PD; Behmoaras J; Sandhu E; McAdoo SP; Prendecki MF; Pickering MC; Botto M; Willicombe M; Thomas DC; Peters JE
    Elife; 2021 Mar; 10():. PubMed ID: 33704068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease.
    Bezerra R; Feitosa ADM; Silvestre OM; Fernandes-Silva MM; Amazonas RB; Teles F; Rodrigues CIS; Lima-Filho JL; Sposito AC; Nadruz W
    Ann Med; 2024 Dec; 56(1):2343890. PubMed ID: 38738416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.
    Haljasmägi L; Salumets A; Rumm AP; Jürgenson M; Krassohhina E; Remm A; Sein H; Kareinen L; Vapalahti O; Sironen T; Peterson H; Milani L; Tamm A; Hayday A; Kisand K; Peterson P
    Sci Rep; 2020 Nov; 10(1):20533. PubMed ID: 33239683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes.
    Viode A; Smolen KK; van Zalm P; Stevenson D; Jha M; Parker K; ; Levy O; Steen JA; Steen H
    Sci Adv; 2024 May; 10(21):eadl5762. PubMed ID: 38787940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
    Cyprian FS; Suleman M; Abdelhafez I; Doudin A; Masud Danjuma M; Mir FA; Parray A; Yousaf Z; Siddiqui MYA; Abdelmajid A; Mulhim M; Al-Shokri S; Abukhattab M; Shaheen R; Elkord E; Al-Khal AL; Elzouki AN; Girardi G
    Front Immunol; 2021; 12():707159. PubMed ID: 34966381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.
    Hsu CM; Weiner DE; Aweh G; Miskulin DC; Manley HJ; Stewart C; Ladik V; Hosford J; Lacson EC; Johnson DS; Lacson E
    Am J Kidney Dis; 2021 May; 77(5):748-756.e1. PubMed ID: 33465417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population.
    Julkunen H; Cichońska A; Slagboom PE; Würtz P;
    Elife; 2021 May; 10():. PubMed ID: 33942721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
    Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
    Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of serum-derived extracellular vesicles are associated with the severity and different clinical profiles of patients with COVID-19: An exploratory secondary analysis.
    Paes Leme AF; Yokoo S; Normando AGC; Ormonde JVS; Domingues RR; Cruz FF; Silva PL; Souza BSF; Dos Santos CC; Castro-Faria-Neto H; Martins CM; Lopes-Pacheco M; Rocco PRM
    Cytotherapy; 2024 May; 26(5):444-455. PubMed ID: 38363248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania.
    Stefan G; Mehedinti AM; Andreiana I; Zugravu AD; Cinca S; Busuioc R; Miler I; Stancu S; Petrescu L; Dimitriu I; Moldovanu E; Crasnaru DE; Gugonea G; Georgescu V; Strambu VD; Capusa C
    Ren Fail; 2021 Dec; 43(1):49-57. PubMed ID: 33307933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.
    Hilbrands LB; Duivenvoorden R; Vart P; Franssen CFM; Hemmelder MH; Jager KJ; Kieneker LM; Noordzij M; Pena MJ; Vries H; Arroyo D; Covic A; Crespo M; Goffin E; Islam M; Massy ZA; Montero N; Oliveira JP; Roca Muñoz A; Sanchez JE; Sridharan S; Winzeler R; Gansevoort RT;
    Nephrol Dial Transplant; 2020 Nov; 35(11):1973-1983. PubMed ID: 33151337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cardiometabolic microRNAs with COVID-19 severity and mortality.
    Gutmann C; Khamina K; Theofilatos K; Diendorfer AB; Burnap SA; Nabeebaccus A; Fish M; McPhail MJW; O'Gallagher K; Schmidt LE; Cassel C; Auzinger G; Napoli S; Mujib SF; Trovato F; Sanderson B; Merrick B; Roy R; Edgeworth JD; Shah AM; Hayday AC; Traby L; Hackl M; Eichinger S; Shankar-Hari M; Mayr M
    Cardiovasc Res; 2022 Jan; 118(2):461-474. PubMed ID: 34755842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
    Park J; Kim H; Kim SY; Kim Y; Lee JS; Dan K; Seong MW; Han D
    Sci Rep; 2020 Dec; 10(1):22418. PubMed ID: 33376242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.
    Ng JH; Hirsch JS; Hazzan A; Wanchoo R; Shah HH; Malieckal DA; Ross DW; Sharma P; Sakhiya V; Fishbane S; Jhaveri KD;
    Am J Kidney Dis; 2021 Feb; 77(2):204-215.e1. PubMed ID: 32961245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.